phosphorylcholine and pi103

phosphorylcholine has been researched along with pi103 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Al-Saffar, NM; Clarke, PA; Jackson, LE; Lacal, JC; Leach, MO; Ramírez de Molina, A; Raynaud, FI; Workman, P	1
Agliano, A; Al-Saffar, NMS; Balarajah, G; Clarke, PA; Jackson, LE; Jones, C; Leach, MO; Marshall, LV; Pearson, ADJ; Sidhu, J; Workman, P	1

Other Studies

2 other study(ies) available for phosphorylcholine and pi103

Article	Year
The phosphoinositide 3-kinase inhibitor PI-103 downregulates choline kinase alpha leading to phosphocholine and total choline decrease detected by magnetic resonance spectroscopy. Cancer research, 2010, Jul-01, Volume: 70, Issue:13 Topics: Adenocarcinoma; Cell Line, Tumor; Choline; Choline Kinase; Down-Regulation; Furans; HCT116 Cells; Humans; Magnetic Resonance Spectroscopy; Male; Membrane Proteins; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylcholine; Prostatic Neoplasms; PTEN Phosphohydrolase; Pyridines; Pyrimidines	2010
In vitro nuclear magnetic resonance spectroscopy metabolic biomarkers for the combination of temozolomide with PI3K inhibition in paediatric glioblastoma cells. PloS one, 2017, Volume: 12, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Child; Dacarbazine; Furans; Glioblastoma; Humans; Lactic Acid; Phosphorylcholine; Proton Magnetic Resonance Spectroscopy; Pyridines; Pyrimidines; Temozolomide; Treatment Outcome	2017

Article

Year

The phosphoinositide 3-kinase inhibitor PI-103 downregulates choline kinase alpha leading to phosphocholine and total choline decrease detected by magnetic resonance spectroscopy.

Cancer research, 2010, Jul-01, Volume: 70, Issue:13

Topics: Adenocarcinoma; Cell Line, Tumor; Choline; Choline Kinase; Down-Regulation; Furans; HCT116 Cells; Humans; Magnetic Resonance Spectroscopy; Male; Membrane Proteins; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylcholine; Prostatic Neoplasms; PTEN Phosphohydrolase; Pyridines; Pyrimidines

2010

In vitro nuclear magnetic resonance spectroscopy metabolic biomarkers for the combination of temozolomide with PI3K inhibition in paediatric glioblastoma cells.

PloS one, 2017, Volume: 12, Issue:7

Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Child; Dacarbazine; Furans; Glioblastoma; Humans; Lactic Acid; Phosphorylcholine; Proton Magnetic Resonance Spectroscopy; Pyridines; Pyrimidines; Temozolomide; Treatment Outcome

2017